BRISTOL, Tenn.--(BUSINESS WIRE)--July 25, 2006--King Pharmaceuticals, Inc. (NYSE:KG - News) reported today that the Company plans to announce its financial results for the second quarter ended June 30, 2006, prior to the market open on Wednesday, August 9, 2006. Conference call information will be provided when available via a subsequent press release. King, headquartered in Bristol, Tennessee, is a vertically integrated branded pharmaceutical company. King, an S&P 500 Index company, seeks to capitalize on opportunities in the pharmaceutical industry through the development, including through in-licensing arrangements and acquisitions, of novel branded prescription pharmaceutical products in attractive markets and the strategic acquisition of branded products that can benefit from focused promotion and marketing and product life-cycle management.
